News NICE backs abiraterone to save lives and NHS costs NICE had previously rejected abiraterone in 2021 due to its high cost Lakshmi Prabha Oct 31, 2025
News Acute migraine? NICE recommends Pfizer's rimegepant as potential option Pb Staff writer Sep 14, 2023
News Evusheld not recommended for adults with severe Covid-19, NICE study reveals pharmacy.biz Staff Feb 16, 2023